Search results
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 3 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 4 days agoVaccine Effectiveness among Household Contacts
Analyst Report: Moderna Inc
Argus Research via Yahoo Finance· 2 days agoModerna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious and cardiovascular ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 5 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report ...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 2 days agoGAMMA Investing LLC grew its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares ...
Gateway - Quartz
Quartz· 4 days agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country ...
Moderna (NASDAQ:MRNA) Stock Price Down 3.9% After Insider Selling
ETF DAILY NEWS· 2 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report)’s share price fell 3.9% during trading on Tuesday following insider selling activity. 1,055,980 shares changed hands during mid-day ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 4 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Market Whales and Their Recent Bets on MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
